Ignite Creation Date:
2024-05-06 @ 12:32 PM
Last Modification Date:
2024-10-26 @ 1:00 PM
Study NCT ID:
NCT03780608
Status:
UNKNOWN
Last Update Posted:
2022-06-15
First Post:
2018-12-18
Brief Title:
This Study is a Phase II Study of AZD6738 in Combination With Durvalumab in Patients With Solid Tumor Cohort A N30 GC Who Have Failed Secondary Chemotherapy Treatments Regimen Cohort B B30 Melanoma Patients Who Have Failed to IO
Sponsor:
Samsung Medical Center
Organization:
Samsung Medical Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-07-30
Start Date Type:
ACTUAL
Primary Completion Date:
2022-12-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-12-01
Completion Date Type:
ESTIMATED
First Submit Date:
2018-12-18
First Submit QC Date:
December 18 2018
Study First Post Date:
2018-12-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-06-13
Last Update Post Date:
2022-06-15
Last Update Post Date Type:
ACTUAL